Interruption of rubella virus transmission in Australia may require vaccination of adult males: evidence from a Victorian sero-survey

Authors

  • Heath Kelly Epidemiology and Surveillance, Victorian Infectious Diseases Reference Laboratory, Locked Bag, 815, Carlton South VIC 3053
  • Theo Karapanagiotidis Victorian Infectious Diseases Reference Laboratory

DOI:

https://doi.org/10.33321/cdi.2004.28.3

Keywords:

rubella, susceptibility, age group, sex

Abstract

Prior to the introduction of rubella vaccine to Australia in 1970 rubella was primarily a disease of primary school aged children. Vaccination programs have subsequently altered rubella age and sex susceptibility. Between July 2001 and June 2002, 85 per cent of the 32 laboratory-confirmed cases of rubella ascertained from enhanced surveillance in Victoria were males aged 20-42 years. This study aimed to determine rubella susceptibility by age group and sex in Victoria and to examine the implications of susceptibility for the interruption of circulating rubella virus. Rubella immunoglobulin G concentrations were determined for 934 residual diagnostic sera stored at the Victorian Infectious Diseases Reference Laboratory using a standard commercial enzyme immunoassay. Susceptibility was analysed by age groups defined by previous and current Australian rubella immunisation schedules. Among all subjects aged 1-55 years, males were more susceptible to rubella infection than females (10.2% vs 2.6%, p<0.0001). Although this sex difference occurred in all age groups, it was unlikely to be explained by sampling variation in sera from subjects aged 23-44 years, for whom rubella vaccine had been recommended only for girls aged 10-14 years and rubella susceptible women post-partum. Australia's past rubella immunisation policies have resulted in a susceptible cohort of adult males. If rubella virus transmission is to be interrupted in Australia, consideration needs to be given to a rubella vaccination program targeting men aged 17-44 years. A campaign, targeting both men and women in a similar age group has recently been successful in Costa Rica. Commun Dis Intell 2004;28:69-73.

Downloads

Download data is not yet available.

References

Chantler J, Wolinsky JS, Tingle A. Rubella virus. In : Knipe DM, Howley PM, editors. Fields Virology. 4th edition. Philidelphia: Lippincott Williams and Wilkins, 2001:963-990.

Gidding HF, Burgess MA, Kempe AE. A short history of vaccination in Australia. Med J Aust 2001;174:37-40.

Sullivan EM, Burgess MA, Forrest JM. The epidemiology of rubella and congenital rubella in Australia, 1992 to 1997. Commun Dis Intell 1999;23:209-214.

Forrest J, Burgess M, Donovan T. A resurgence of congenital rubella in Australia? Commun Dis Intell 2003;27:533-536.

Bart KJ, Orenstein WA, Preblud SR, Hinman AR. Universal immunization to interrupt rubella. Rev Infect Dis 1985;7 Suppl 1:S177-S184.

Gilbert GL, Escott RG, Gidding HF, Turnbull FM, Heath TC, McIntyre PB, et al. Impact of the Australian Measles Control Campaign on immunity to measles and rubella. Epidemiol Infect 2001;127:297-303.

Guy RJ, Andrews RM, Kelly HA, Leydon JA, Riddell MA, Lambert S, et al. Mumps and rubella: a year of enhanced surveillance and laboratory testing. Epidemiol Infect. In press, 2004.

Peltola H, Davidkin I, Paunio M, Valle M, Leinikki P, Heinonen OP. Mumps and rubella eliminated from Finland. JAMA 2000;284:2643-2647.

World Health Organization, Department of Vaccines and Biologicals. Report of a meeting on preventing congenital rubella syndrome: immunization strategies, surveillance needs. Geneva: World Health Organization; 2000 12 -14 January. Report No.: WHO/V&B/00.10.

Top of page

Kelly HA, Riddell MA, Lambert SB, Leydon JA, Catton MG. Measles immunity among young adults in Victoria. Commun Dis Intell 2001;25:129-132.

Campbell M. Young adult measles vaccination [editorial]. Commun Dis Intell 2000;24:241-242.

Lambert SB, Morgan ML, Riddell MA, Andrews RM, Kelly HA, Leydon JA, et al. Measles outbreak in young adults in Victoria, 1999. Med J Aust 2000;173:467-471.

Davidson N, Andrews R, Riddell M, Leydon J, Lynch P. A measles outbreak among young adults in Victoria, February 2001. Commun Dis Intell 2002;26:273-278.

Counahan M, Tobin S, Andrews R, Robinson P, Chibo D, Riddell M. Measles-get vaccinated! Vic Infect Dis Bull 2003;6:33-34.

Kelly H, Riddell MA, Gidding HF, Nolan T, Gilbert GL. A random cluster survey and a convenience sample give comparable estimates of immunity to vaccine preventable diseases in children of school age in Victoria, Australia. Vaccine 2002;20:3130-3136.

Francis BH, Thomas AK, McCarty CA. The impact of rubella immunization on the serological status of women of childbearing age: a retrospective longitudinal study in Melbourne, Australia. Am J Pub Health 2003;93:1274-1276.

Gidding HF, Gilbert GL. Measles immunity in young Australian adults. Commun Dis Intell 2001;25:133-136.

Cheffins T, Chan A, Keane RJ, Haan EA, Hall R. The impact of rubella immunisation on the incidence of rubella, congenital rubella syndrome and rubella-related terminations of pregnancy in South Australia. Br J Obstet Gynaecol 1998;105:998-1004.

Hinman AR, Hersh BS, de Quadros CA. Rational use of rubella vaccine for prevention of congenital rubella syndrome in the Americas. Rev Panam Salud Publica. 1998;4:156-160.

Measles, rubella, and congenital rubella syndrome--United States and Mexico, 1997-1999. MMWR Morb Mortal Wkly Rep 2000;49:1048-1059.

Castillo-Soloranzo C, Carrasco P, Tambini G, Reef S, Brana M, de Quadros CA. New horizons in the control of rubella and prevention of congenital rubella syndrome in the Americas. J Infect Dis 2003;187 Suppl 1:S146-S152.

Morice A, Carvajal X, Leon M, Machado V, Badilla X, Reef S, et al. Accelerated rubella control and congenital rubella syndrome prevention strengthen measles eradication: the Costa Rican experience. J Infect Dis 2003;187 Suppl 1:S158-S163.

Downloads

Published

30/03/04

How to Cite

Kelly, Heath, and Theo Karapanagiotidis. 2004. “Interruption of Rubella Virus Transmission in Australia May Require Vaccination of Adult Males: Evidence from a Victorian Sero-Survey”. Communicable Diseases Intelligence 28 (March):69-73. https://doi.org/10.33321/cdi.2004.28.3.

Most read articles by the same author(s)

1 2 > >>